Drug Storage & Distribution
Drug Return & Destruction
Marken’s global GMP depots manage returns from clinical sites, perform the reception and reconciliation of returns and provide destruction by locally approved and qualified destruction vendors. All required documentation is provided, including destruction certificates to allow traceability of the destroyed clinical supplies.
Related resources
Marken: Patient-Centric Supply Chain Solutions
14 April 2023
Patient, doctor and industry interest continues to shift dramatically towards siteless and hybrid clinical trials. Marken’s comprehensive suite of patient-centric…
Marken Delivers Lifesaving Intravenous Therapy from Pennsylvania to Sites Across the USA Within 24 Hours
9 February 2023
Marken successfully delivered the time-critical intravenous therapy, Legalon, from its GMP Philadelphia depot to sites across the USA to treat…
Marken Successfully Delivers Lifesaving Apheresis Treatment From The USA to the UK Within 24 Hours
9 February 2023
Marken was tasked with performing a next-day collection of temperature-sensitive tumor material from Philadelphia to Manchester, UK for an urgent…
Optimizing Storage and Distribution in an Era of Clinical Trial Transformation
4 January 2023
Strategic storage and distribution are pivotal pieces in the orchestration of delivering lifesaving treatments to patients throughout the entire pharmaceutical…
Marken Successfully Safeguards the Viability of Pharmaceutical Samples Within 42 Hours
4 January 2023
The distribution of critical cell samples requires an agile strategy with contingency planning and regulatory expertise to ensure seamless delivery…
Happy Holidays from Marken
21 December 2022
At Marken, we are passionate about patients – always finding a way to deliver for our clients – on-time, within…
Marken Overcomes Multiple Obstacles To Successfully Deliver Critical Stem Cell Samples Across The Globe
9 December 2022
Stem cell samples require extremely tight 24-hour turnaround times in order to be modified and processed for critical cell therapy…
Marken Successfully Ships Lifesaving Treatments For Humanitarian Aid In Ukraine
24 June 2022
Marken successfully transported critical compassionate use medicinal products and supplies as part of a humanitarian effort in Ukraine. Mitigating the…
Decentralized Trial Logistics Requires Thoughtful Strategy: Marken
22 September 2021
Outsourcing Pharma and Marken President Ariette van Strien discuss the complexity of decentralized trials and considerations for crafting a strategic…
Fortifying Logistics With Technology for Decentralized Trials
11 August 2021
Contract Pharma and Wes Wheeler, President of UPS Healthcare, discuss the partnership between Marken and THREAD, a decentralized clinical trial…
What a Global Pandemic Taught Us About the Pharmaceutical Supply Chain
10 August 2021
The COVID-19 pandemic highlighted both the strengths and weaknesses of the pharmaceutical supply chain. In this article for peer-reviewed Journal…
Personalized Medicine Requires Complex Supply Chains: Marken
26 July 2021
Outsourcing-Pharma and Nina Vas, Marken’s Vice President, Clinical Distribution, Cell and Gene Therapy Supply Chain, discuss the specific requirements involved…
Understanding why we must adapt, continuously asking ourselves how we can change what matters is how we keep on delivering it.
Login and quick links